Menu
FDA · Medical device recall

Mission -Breath Alcohol Detector -15 tests…

Aug. 5, 2015 Class III

Date
Aug. 5, 2015
Risk class
Class III (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences)
Status
Terminated
Filed by
Acon Laboratories, Inc.
Product
Mission -Breath Alcohol Detector -15 tests - 0.08% BAC - Blow bags included Product Usage: The Breath Alcohol Detector is for the semi-quantitative rapid detection of the presence of alcohol in the exhaled breath. The Breath Alcohol Detector indicated relative Blood Alcohol Concentration (BAC) at 0.02%, 0.04%, 0.05%, 0.06%, 0.08%, or 0.10% cut-off levels.
Reason
Acon Laboratories, Inc. is recalling Mission Breath Alcohol Detector due to a labeling amendment.
Distribution pattern
U.S. Nationwide Distribution in the states of: NY, CA, FL, VA, LA, NJ, MN, PA, MI, OH, TX, VA, UT, AL, and GA
Quantity
1,283 kits
Codes and lots
-BAD4040003 (48 kits) -BAD4080006 (59 kits) -BAD5010010/BAD5040013/BAD5010011 (total of 1,176 kits)
Recall started
June 17, 2015
Device type
Devices, Breath Trapping, Alcohol
Root cause (FDA)
Labeling False and Misleading
What the company told customers
On 06/17/15 the firm sent out customer notification letters to their distributors. The letter identified the affected product, problem and actions to be taken. In the letter the firm requests that Mission Breath Alcohol Detectors be quarantined. The firm asks that distributor complete the "fax back" form to allow for the return of unexpired product for a replacement. Once the form is received the firm is going to issue a return authorization number as well as provide a return label. The contact noted in the letter is Qiyi Xie MD, MPH, Sr. Officer Regulatory and Clinical Affairs at 858-857-8011.
Recall number
Z-2322-2015

What should I do? How serious is a recall? Classes and warnings explained

Source: FDA · Medical device enforcement report, recall number Z-2322-2015. The agency record governs; check it and the company before acting.

Report a mistake on this page